SARAH ENLOW: Open Payments
NPI 1639838824 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 74 payments from 12 companies in 2025. Trend: 2023 $536 · 2024 $294 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $231 |
| Otsuka America Pharmaceutical, Inc. | 16 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $152 |
| Axsome Therapeutics, Inc. | 15 | $143 |
| Alkermes, Inc. | 4 | $68 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $21 |
| Indivior Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, Auvelity, ABILIFY ASIMTUFII, REXULTI, ARISTADA, QULIPTA, APTIMA.
Industry payments across IN — which companies pay providers there.
